Gang Chen is a Chinese-born engineer, nanotechnologist at Massachusetts Institute of Technology
Boston:
A professor at the Massachusetts Institute of Technology who specializes in nanotechnology research was arrested on U.S. charges that he failed to disclose his ties to the Chinese government when seeking federal grant money.
Federal prosecutors in Boston on Thursday charged Gang Chen, a Chinese-born mechanical engineer and nanotechnologist, with defrauding the U.S. Department of Energy when seeking grants and failing to disclose a foreign bank account on a tax return.
Following his arrest, the Federal Bureau of Investigation executed search warrants at his home in Cambridge and office at MIT, where he is the director of the MIT Pappalardo Micro/Nano Engineering Laboratory.
MIT professor charged over funding from China
Bloomberg
A Massachusetts Institute of Technology (MIT) professor and nanotechnology expert has been charged with failing to disclose to the US Department of Energy millions of dollars in funding he allegedly received from China, the latest in a slew of similar cases.
Chen Gang (陳剛), 56, a naturalized US citizen from China, was charged with wire fraud, making a false statement in a tax return and failing to disclose a foreign bank account, the US Department of Justice said.
In a court appearance by videoconference, a federal judge in Boston on Thursday said that he anticipated requiring Chen to post a secured bond “in the neighborhood” of US$1 million.
Science’
s COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.
On 2 January 2020, a group of clinician-researchers at the Jinyintan Hospital here, along with colleagues at other institutions, launched a study of 41 patients suffering from a new, atypical pneumonia. The team assembled clinical data, laboratory results, and chest x-rays; tracked the production of immune system molecules called cytokines; and noted the use of antivirals, antibiotics, and corticosteroids. Thirteen of the patients required intensive care, and six died.
The group’s observations, published online by
The Lancet on 24 January 2020, were the first dispatch from the clinical front lines of the COVID-19 pandemic and gave clinicians around the world a detailed picture of what to brace for as the virus, then called 2019-nCoV, began to race across the globe. The paper also contained a clear warning: “We are concerned that 2019-nCoV could have acquired the ability for
Medical workers take care of a COVID-19 patient at Union Hospital in Wuhan, China, in April 2020.
PHOTO: XINHUA/SHEN BOHAN/GETTY IMAGES
On 2 January 2020, a group of clinician-researchers at the Jinyintan Hospital here, along with colleagues at other institutions, launched a study of 41 patients suffering from a new, atypical pneumonia. The team assembled clinical data, laboratory results, and chest x-rays; tracked the production of immune system molecules called cytokines; and noted the use of antivirals, antibiotics, and corticosteroids. Thirteen of the patients required intensive care, and six died.
The group s observations, published online by
The Lancet on 24 January 2020, were the first dispatch from the clinical front lines of the COVID-19 pandemic and gave clinicians around the world a detailed picture of what to brace for as the virus, then called 2019-nCoV, began to race across the globe. The paper also contained a clear warning: “We are concerned that 2019-nCoV coul